Related Experiment Video
Updated: Oct 3, 2025
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.6K
Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral
Huei-Kai Huang1, Peter Pin-Sung Liu2, Shu-Man Lin3
1Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, and Department of Family Medicine and Department of Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan (H.K.H.).
Annals of Internal Medicine
|February 14, 2022
Summary
Non-vitamin K antagonist oral anticoagulants (NOACs) significantly reduced diabetes complications and mortality in atrial fibrillation patients compared to warfarin. This finding offers crucial insights for managing these complex conditions.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Limited evidence exists on oral anticoagulant risks for diabetes complications in atrial fibrillation (AF) and diabetes mellitus (DM) patients.
- Understanding these risks is crucial for optimizing patient care and treatment strategies.
Purpose of the Study:
- To compare the risks of diabetes complications and mortality between non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin users.
- To provide evidence-based guidance for anticoagulant selection in patients with AF and DM.
Main Methods:
- Retrospective cohort study using nationwide Taiwanese health insurance data (2012-2017).
- Compared outcomes between NOAC and warfarin users, employing propensity score methods for confounder balancing.
- Investigated hazards of macrovascular, microvascular, glycemic emergencies, and all-cause mortality.
Main Results:
- NOAC users (19,909) showed significantly lower hazards of macrovascular complications (HR 0.84), microvascular complications (HR 0.79), glycemic emergency (HR 0.91), and mortality (HR 0.78) versus warfarin users (10,300).
- Propensity score matching and sensitivity analyses confirmed these robust findings.
Conclusions:
- NOACs are associated with reduced risks of diabetes complications and mortality compared to warfarin in patients with AF and DM.
- These findings support the use of NOACs for improved outcomes in this patient population.
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.4K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.4K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
975
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
975
01:29Venous Thrombosis III: Interprofessional Care
43
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
43
01:30Coronary Artery Disease III: Clinical Manifestations
54
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
54
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
3.3K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.3K
01:30Venous Thrombosis IV: Nursing Management
42
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
42